InnoCare Pharma Inc. Reports Ownership in Zenas BioPharma, Inc.

InnoCare Pharma Inc. has reported ownership of 5,000,000 shares of common stock in Zenas BioPharma, Inc. as of October 7, 2025. The filing, submitted under Form 3, indicates that InnoCare Pharma Inc. is a 10% owner of Zenas BioPharma, Inc. The shares are held directly by InnoCare Pharma Inc. The filing was signed by Jisong Cui, Chairperson and CEO of Zenas BioPharma, Inc., on October 15, 2025.